Abeona Therapeutics Inc
F:PCJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
Tecan Group AG
OTC:TCHBF
|
CH |
|
Fomento de Construcciones y Contratas SA
F:FCC0
|
ES |
|
A
|
Axon Enterprise Inc
F:TCS
|
US |
|
P
|
Petrofac Ltd
F:P2F
|
JE |
|
TechnologyOne Ltd
F:RW8
|
AU |
|
A
|
Adidas AG
F:ADS
|
DE |
|
F
|
Fomento de Construcciones y Contratas SA
XMUN:FCC
|
ES |
Wall St Price Targets
PCJ Price Targets Summary
Abeona Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for PCJ is 16.449 EUR with a low forecast of 10.587 EUR and a high forecast of 23.706 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCJ's stock price target?
Price Target
16.449
EUR
According to Wall Street analysts, the average 1-year price target for PCJ is 16.449 EUR with a low forecast of 10.587 EUR and a high forecast of 23.706 EUR.
What is the Revenue forecast for Abeona Therapeutics Inc?
Projected CAGR
71%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 71%.
What is the Net Income forecast for Abeona Therapeutics Inc?
Projected CAGR
16%
The compound annual growth rate for Net Income over the next 8 years is 16%.
